Evidence map›Paper›PMID 20838952›Full record

ArticleNeurotoxicity research2011

Ontogenetic serotoninergic lesioning alters histaminergic activity in rats in adulthood.

Jadwiga Jośko, Jacek Drab, Jerzy Jochem, Przemysław Nowak, Ryszard Szkilnik, Eva Korossy-Mruk, Dariusz Boroń, Richard M Kostrzewa, Halina Brus, Ryszard Brus

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jadwiga JośkoDepartment of Environmental Medicine and Epidemiology, Medical University of Silesia, 41-808, Zabrze, Poland.
Jacek Drab
Jerzy Jochem
Przemysław Nowak
Ryszard Szkilnik
Eva Korossy-Mruk
Dariusz Boroń
Richard M Kostrzewa
Halina Brus
Ryszard Brus
Medical University of Silesia · PLEast Tennessee State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to determine histamine content in the brain and the effect of histamine receptor antagonists on behavior of adult rats lesioned as neonates with the serotonin (5-HT) neurotoxin 5,7-dihydroxytryptamine (5,7-DHT). At 3 days after birth Wistar rats were pretreated with desipramine (20 mg/kg ip) before bilateral icv administration of 5,7-DHT (37.5 μg base on each side) or saline-ascorbic (0.1%) vehicle (control). At 10 week levels of 5-HT and its metabolite 5-hydroxyindole acetic acid (5-HIAA) were determined in frontal cortex, striatum, and hippocampus by an HPLC/ED technique. In the hypothalamus, frontal cortex, hippocampus and medulla oblongata, the level of histamine was analyzed by an immunoenzymatic method. Behavioral observations (locomotion, exploratory-, oral-, and stereotyped activity) were performed, and effects of DA receptor agonists (SKF 38393, apomorphine) and histamine receptor antagonists S(+)chlorpheniramine (H(1)), cimetidine (H(2)), and thioperamide (H(3)) were determined. We confirmed that 5,7-DHT profoundly reduced contents of 5-HT and 5-HIAA in the brain in adulthood. Histamine content was also reduced in all examined brain regions. Moreover, in 5,7-DHT-lesioned rats the locomotor and oral activity responses to thioperamide were altered, and apomorphine-induced stereotype was intensified. From the above, we conclude that an intact central serotoninergic system modulates histamine H(3) receptor antagonist effects on the dopaminergic neurons in rats.

Indexed as

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine5,7-DihydroxytryptamineAnimalsAnimals, NewbornApomorphineBrain InjuriesChromatography, High Pressure LiquidDesipramineDopamine AgonistsDose-Response Relationship, DrugDrug InteractionsElectrochemistryEnzyme InhibitorsHistamineHistamine AntagonistsHydroxyindoleacetic Acid2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine5,7-DihydroxytryptamineApomorphineDesipramineDopamine AgonistsEnzyme InhibitorsHistamineHistamine AntagonistsHydroxyindoleacetic AcidSerotoninSerotonin Agents

Identifiers

PMID20838952
OpenAlexW2093501288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.